Three general insurance stocks finished within a percentage point of the 10% upper circuit limit on the same day. Same sector. Same session. Different size brackets — a small-cap, a mid-cap, and a large-cap. That has not happened on the Dhaka Stock Exchange in months, and the strength is not subtle.
PURABIGEN closed at Tk 31.70, up 9.69%, hitting a fresh 52-week high at the bell. JANATAINS finished at Tk 37.40, up 9.04%. RELIANCINS settled at Tk 94.20, up 6.80% after touching Tk 96.50 intraday. Together the three names absorbed nearly seven million shares of buying interest while the DSEX added 33.57 points to close at 5,406.20 on turnover of Tk 1,080 crore — the second consecutive session above the Tk 1,000 crore threshold and an 18% jump from June 1’s already-elevated Tk 912 crore.
The headline numbers are unusual enough. The pattern underneath them is what matters.
The Two-Day Rotation Pattern
On Monday, banking ran the show. Seven of the top ten DSEX index contributors were banks. NCCBANK, BRACBANK, CITYBANK, and JAMUNABANK dominated turnover, and the message was straightforward: institutional money returning from a week-long Eid holiday wanted liquidity, size, and visibility first.
On Tuesday, that money moved.
JAMUNABANK and BRACBANK still topped the turnover board — Tk 359 million and Tk 285 million respectively — but neither moved more than a fraction of a percent. The bid was off the banks. It was on insurance. Three insurers in the top ten gainers, average gain 8.51%. The strongest single sector showing since the May 7 general insurance breakout, which produced a 2.5% sector gain — but with the individual stocks moving roughly four times as hard this time around.
That sequencing — banking Day 1, insurance Day 2 — is not coincidence. It is the textbook signature of post-holiday sector rotation. Day 1 buying targets safety and liquidity. Day 2 buying targets relative value once the obvious names have been bid up. Insurance, after eighteen months as one of the DSE’s worst-performing sectors, was the cheapest territory left standing.
The Valuation Gap That Pulled the Money
RELIANCINS trades at a price-to-earnings ratio of 10.48. The average DSE-listed bank trades closer to 12 to 15. JANATAINS sits at a richer 35.56 — small-cap insurer math — but its share price is still 1.84% below its 52-week high, and the company has gained 79% year-to-date despite weak earnings. PURABIGEN’s P/E of 19.79 sounds high in isolation; against the fact that its stock has doubled from a 52-week low of Tk 15.30 and now sits exactly at its 52-week high of Tk 31.70, the multiple looks like the market repricing a name that had been written off.
That repricing thesis is the cleanest read on Tuesday’s session. None of these companies announced anything material. None reported a fresh quarter. The catalyst was not company-specific. It was structural — institutional desks running the same screen on the same morning and arriving at the same answer: insurance was too cheap relative to where banking had just been pushed. The same logic that drove the May 19 pre-Eid insurance recovery has returned at higher intensity.
What the Earnings Numbers Are Not Saying
Here is what makes the rally complicated. Every one of the three focus stocks shows declining year-on-year EPS. JANATAINS earnings are down 21.1%. PURABIGEN down 15.8%. RELIANCINS down 7.7%. Revenue is contracting at JANATAINS (-7.7%) and PURABIGEN (-14.7%). Only RELIANCINS shows top-line growth (+14.1%), and even there the bottom line is shrinking.
DSE also published auditor opinion disclosures Tuesday for multiple insurance names. PURABIGEN and JANATAINS both carry an Emphasis of Matter note in their FY2025 reports. EASTERNINS, UNIONINS, and BGIC received the harsher Qualified Opinion designation. This is year-end disclosure season, not a fresh negative signal — but it sat in the public record while the buyers showed up anyway.
The tension matters. The rally is being driven by valuation re-rating and sector rotation, not by fundamental improvement. Buyers know the earnings are weak. They are betting that the sector was oversold for too long, and that the post-Eid liquidity rotating out of conviction-bid banking names has to land somewhere. Insurance is where it landed.
What to Watch Next
PURABIGEN closed at its 52-week high. JANATAINS sits 1.84% below its own. RELIANCINS is 3.68% off. Two of three nearly hit the upper circuit and stopped just short — supply did come out at the highs, which means the next session is the test. Rallies that absorb selling at resistance tend to extend. Rallies that fail to clear it on Day 2 tend to give back fast.
The signals to track are narrow. Whether the three names hold their gains on Wednesday. Whether the rotation extends to other oversold corners — NBFIs, mid-cap engineering, or the broader insurance complex beyond these three names — or whether it stalls inside today’s gainers and starts churning. Whether turnover holds above Tk 1,000 crore for a third straight session, which would convert a two-day rotation into a sustained re-engagement of the market.
Tuesday answered the question of where post-Eid money was going. Wednesday will answer whether that money is staying.